Latest Blog Posts
Search
Sort Results
Filter by Topic
Filter by Resource Category
Search results
Current filters: Hepatitis C, Infections and cancers, Cancers
10 search results
- Caution needed about claims of increased risk of liver cancer recurrence with use of DAAs
-
From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage - Looking back at liver cancer rates among people who received interferon therapy
-
From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage - Barcelona: Reports of unexpected cases of liver cancer in people undergoing treatment with DAAs
-
From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage - Vienna doctors urge caution when assessing possible associations between liver cancer recurrence and use of DAAs
-
From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage - Bologna researchers find no link between DAAs and liver cancer
-
From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage - Large review from three French studies finds no link between use of DAAs and recurrence of liver cancer
-
From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage - Euro-Canadian study looks at trends in liver cancer in co-infected people
-
2016, CATIE
Research summary - Webpage - U.S. study looks at long-term durability of cure, risk of relapse and liver cancer
-
From TreatmentUpdate 215
2016, CATIE
Research summary - Webpage - A note on liver cancer in Canada
-
From TreatmentUpdate 197
2013, CATIE
Research summary - Webpage - Liver cancer—risk factors, screening and treatment options
-
From TreatmentUpdate 197
2013, CATIE
Research summary - Webpage
